We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
-$163M
Cap. Flow
-$390M
Cap. Flow %
-17.16%
Top 10 Hldgs %
60.11%
Holding
1,283
New
44
Increased
84
Reduced
363
Closed
631

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$34.6M
2
APH icon
Amphenol
APH
+$26.5M
3
ICE icon
Intercontinental Exchange
ICE
+$18.2M
4
FAST icon
Fastenal
FAST
+$12.5M
5
TXN icon
Texas Instruments
TXN
+$12.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$68.4M
2
AMZN icon
Amazon
AMZN
+$32.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$25M
4
DAVA icon
Endava
DAVA
+$22.8M
5
MSFT icon
Microsoft
MSFT
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 27.54%
2 Financials 24.9%
3 Consumer Discretionary 12.74%
4 Communication Services 11.34%
5 Healthcare 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAAU icon
626
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.71B
– –
-5,500
Closed -$96K
AAL icon
627
American Airlines Group
AAL
$9.03B
– –
-1,432
Closed -$29.4K
ACB
628
Aurora Cannabis
ACB
$254M
– –
-25
Closed -$1.74K
ACM icon
629
Aecom
ACM
$8.9B
– –
-158
Closed -$9.98K
ACRS icon
630
Aclaris Therapeutics
ACRS
$885M
– –
-195
Closed -$3.51K
ACU icon
631
Acme United Corp
ACU
$242M
– –
-1,200
Closed -$39.3K
ADAP
632
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-7,050
Closed -$36.4K
ADCT icon
633
ADC Therapeutics
ADCT
$146M
– –
-115
Closed -$3.12K
ADN
634
DELISTED
Advent Technologies
ADN
– –
-20
Closed -$5.31K
ADPT icon
635
Adaptive Biotechnologies
ADPT
$4.02B
– –
-67
Closed -$2.28K
ADSK icon
636
Autodesk
ADSK
$55B
– –
-259
Closed -$73.9K
ADT icon
637
ADT
ADT
$5.51B
– –
-1,250
Closed -$10.1K
AEM icon
638
Agnico Eagle Mines
AEM
$104B
– –
-2,085
Closed -$108K
AER icon
639
AerCap
AER
$23.2B
– –
-680
Closed -$39.3K
AG icon
640
First Majestic Silver
AG
$10.2B
– –
-18,226
Closed -$206K
AGG icon
641
iShares Core US Aggregate Bond ETF
AGG
$138B
– –
-73
Closed -$8.38K
AGI icon
642
Alamos Gold
AGI
$15.4B
– –
-86
Closed -$619
AI icon
643
C3.ai
AI
$1.64B
– –
-792
Closed -$36.7K
AKRO
644
DELISTED
Akero Therapeutics
AKRO
– –
-100
Closed -$2.23K
AL
645
DELISTED
Air Lease Corp
AL
– –
-450
Closed -$17.7K
CHGA
646
Change Agents Corp
CHGA
$142K
– –
-2
Closed -$222
ALEC icon
647
Alector
ALEC
$261M
– –
-91
Closed -$2.08K
ALK icon
648
Alaska Air
ALK
$4.72B
– –
-742
Closed -$43.5K
AMX icon
649
America Movil
AMX
$69.4B
– –
-1,000
Closed -$17.7K
APA icon
650
APA Corp
APA
$14.9B
– –
-180
Closed -$3.86K
24 25
26
27 28

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q4 2021 Portfolio in Review

As of Q4 2021, RBC Europe held 1,283 positions worth $2.27B, down 6.7% from $2.44B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

RBC Europe withdrew a net $390M in Q4 2021, closing 631 positions and reducing 363 holdings. Its most notable exit was Endava, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, RBC Europe opened a new position in Brown & Brown worth $2.02M.

  • RBC Europe's largest Q4 2021 buy was Brown & Brown: 28,685 shares worth $2.02M.
  • RBC Europe added most to Thermo Fisher Scientific in Q4 2021, an estimated $34.6M increase.
  • RBC Europe's biggest Q4 2021 reduction was Apple, cutting an estimated $68.4M.
  • RBC Europe fully exited Endava in Q4 2021, selling an estimated $22.8M.
  • RBC Europe's ten largest holdings make up 60% of its $2.27B portfolio in Q4 2021.
  • RBC Europe opened 44 new positions and closed 631 in Q4 2021.
  • RBC Europe's portfolio value fell 6.7% quarter-over-quarter to $2.27B.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.